High Deal Valuations & Volumes Will Persist, Industry Dealmakers Predict
Big pharma business development executives forecast a competitive and active deal-making year ahead for the industry at the Biocom partnering conference.
Big pharma business development executives forecast a competitive and active deal-making year ahead for the industry at the Biocom partnering conference.